Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

ISOLeucine Addition Treatment Effects (ISOLATE) in a Controlled Diet Study

NCT07329088 is registered in ClinicalTrials.gov with Jean L. Fry as lead sponsor.

NCT NCT07329088
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07329088 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
ISOLeucine Addition Treatment Effects (ISOLATE) in a Controlled Diet Study
Lead sponsor
Jean L. Fry
Phase
Not applicable
Overall status
Withdrawn
Start date
May 4, 2026
Completion date
January 31, 2029
Enrollment
0 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

metabolic syndrome (mets), obesity & overweight, prediabetes (insulin resistance, impaired glucose tolerance)